EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Lessons From Astaxanthin Therapy to Combat Oral Premalignant and Malignant Lesions: A Narrative Review

Reza Arefnezhad, Zhina Mohamadi, Shervin Shahianjahromi, Amirali Fallahian, Maryam Ashrafi, Armin Nikdehqan, Mitra Saeedi Valashani, Reza Nasiri, Fatemeh Zeinali, Hossein Fatemian, Niloofar Sefati, Fatemeh Rezaei-Tazangi iD und 1 weitere

Health Science Reports · 2026-07 · 9 (7)

DOI: 10.1002/hsr2.72712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 30.06.2026. Verfasst von Reza Arefnezhad und 12 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee Fasa University of Medical Sciences Fasa Iran. Die Arbeit nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Oral cancer is one of the most common head and neck malignancies and remains associated with high morbidity, mortality, and treatment‐related toxicity. Despite advances in surgery, radiotherapy, and chemotherapy, there is still a need for safer adjunctive therapies with better therapeutic potential.

Results

Astaxanthin, a natural lipophilic carotenoid, has gained attention because of its antioxidant, anti‐inflammatory, and anticancer activities. The available evidence suggests that astaxanthin may suppress oral premalignant and malignant progression by inhibiting inflammation, oxidative stress, proliferation, invasion, angiogenesis, and survival signaling pathways, while promoting apoptosis and reactivating tumor suppressor mechanisms. Preclinical studies also indicate that astaxanthin‐based formulations may improve delivery efficiency and enhance antitumor effects in oral cancer models.

Conclusion

Overall, astaxanthin appears to be a promising natural candidate for oral cancer prevention and treatment. However, most findings are based on preclinical studies, and further well‐designed clinical investigations are required to confirm its efficacy and safety.

Schlagwörter

Stichwörter der Autor:innen

astaxanthinoral canceroral malignant lesionsoral premalignant lesions

Autor:innen und Institutionen

  • Student Research Committee Fasa University of Medical Sciences Fasa Iran.
  • Student Research Committee Shiraz University of Medical Sciences Shiraz Iran.
  • Faculty of Medicine Kermanshah University of Medical Sciences Kermanshah Iran.
  • Shiraz Dental School Shiraz University of Medical Sciences Shiraz Iran.
  • Registered Dental Hygienist Vancouver British Columbia Canada.
  • Department of Dermatology, School of Medicine, Rasool Akram Medical Complex Iran University of Medical Sciences (IUMS) Tehran Iran.

ORCID-Profile: Fatemeh Rezaei-Tazangi

Zitieren

APA

Arefnezhad, R., Mohamadi, Z., Shahianjahromi, S., Fallahian, A., Ashrafi, M., Nikdehqan, A., Valashani, M. S., Nasiri, R., Zeinali, F., Fatemian, H., Sefati, N., Rezaei-Tazangi, F., & Tavakoli, M. R. (2026). Lessons From Astaxanthin Therapy to Combat Oral Premalignant and Malignant Lesions: A Narrative Review. Health Science Reports, 9(7). https://doi.org/10.1002/hsr2.72712

Vancouver

Arefnezhad R, Mohamadi Z, Shahianjahromi S, Fallahian A, Ashrafi M, Nikdehqan A, et al. Lessons From Astaxanthin Therapy to Combat Oral Premalignant and Malignant Lesions: A Narrative Review. Health Science Reports. 2026;9(7). doi:10.1002/hsr2.72712

BibTeX
@article{Arefnezhad2026,
  author = {Arefnezhad, Reza and Mohamadi, Zhina and Shahianjahromi, Shervin and Fallahian, Amirali and Ashrafi, Maryam and Nikdehqan, Armin and Valashani, Mitra Saeedi and Nasiri, Reza and Zeinali, Fatemeh and Fatemian, Hossein and Sefati, Niloofar and Rezaei-Tazangi, Fatemeh and Tavakoli, Marziye Ranjbar},
  title = {Lessons From Astaxanthin Therapy to Combat Oral Premalignant and Malignant Lesions: A Narrative Review},
  journal = {Health Science Reports},
  year = {2026},
  volume = {9},
  number = {7},
  doi = {10.1002/hsr2.72712}
}
Kostenlos starten →